XOMA ASKING COURT FOR 40% ROYALTIES FROM CENTOCOR’s CENTOXIN U.S. SALES; FDA RAISES ADDITIONAL CENTOXIN ISSUES; TOCOR II OFFERING NETS CENTOCOR $84 MIL.